Literature DB >> 16255751

Prediction of the recurrence of atrial fibrillation after successful cardioversion with P wave signal-averaged ECG.

Marco Budeus1, Marcus Hennersdorf, Christian Perings, Heinrich Wieneke, Raimund Erbel, Stefan Sack.   

Abstract

BACKGROUND: The recurrence of atrial fibrillation (AF) was often observed after cardioversion.
METHODS: In our study, a P wave triggered P wave signal-averaged ECG (P-SAECG) was performed on 118 consecutive patients 1 day after successful electrical cardioversion in order to evaluate the utility of this method to predict AF after cardioversion. We measured the filtered P wave duration (FPD) and the root mean square voltage of the last 20 ms of the P wave (RMS 20).
RESULTS: During a 1-year follow-up, a recurrence was observed in 57 patients (48%). Patients with recurrence of AF had a larger left atrial size (41.9 +/- 4.0 vs 39.3 +/- 3.1 mm, P < 0.0003), a longer FPD (139.6 +/- 16.0 vs 118.2 +/- 14.1 ms, P < 0.0001), and a lower RMS 20 (2.57 +/- 0.77 vs 3.90 +/- 0.99 microV, P < 0.0001). A cutoff point (COP) of FPD > or =126 ms and RMS 20 < or =3.1 microV could predict AF with a specificity of 77%, a sensitivity of 72%, a positive value of 75%, a negative predictive value of 75%, and an accuracy of 75%. A stepwise logistic regression analysis of variables identified COP (odds ratio 9.97; 95% CI, 4.10-24.24, P < 0.0001) as an independent predictor for recurrence.
CONCLUSIONS: We conclude that the probability of recurrence of AF after cardioversion could be predicted by P-SAECG. This method seems to be appropriate to demonstrate a delayed atrial conduction that might be a possible risk factor of reinitiation of AF.

Entities:  

Mesh:

Year:  2005        PMID: 16255751      PMCID: PMC6932341          DOI: 10.1111/j.1542-474X.2005.00059.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  26 in total

1.  Electrophysiologic predictors of the recurrence of persistent atrial fibrillation within 30 days of cardioversion.

Authors:  Merritt H Raitt; Walter Kusumoto; George D Giraud; John H McAnulty
Journal:  Am J Cardiol       Date:  2004-01-01       Impact factor: 2.778

2.  Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

Authors:  D Roy; M Talajic; P Dorian; S Connolly; M J Eisenberg; M Green; T Kus; J Lambert; M Dubuc; P Gagné; S Nattel; B Thibault
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

3.  Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation.

Authors:  S Lévy; P Ricard; C P Lau; N S Lok; A J Camm; F D Murgatroyd; L J Jordaens; L J Kappenberger; P Brugada; K L Ripley
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

4.  Effects of amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease.

Authors:  W Banasiak; A Telichowski; S D Anker; A Fuglewicz; D Kalka; W Molenda; K Reczuch; J Adamus; A J Coats; P Ponikowski
Journal:  Am J Cardiol       Date:  1999-01-01       Impact factor: 2.778

5.  Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation.

Authors:  M A Brodsky; B J Allen; E V Capparelli; C R Luckett; R Morton; W L Henry
Journal:  Am J Cardiol       Date:  1989-05-01       Impact factor: 2.778

6.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

7.  Early recurrence of atrial fibrillation after ambulatory shock conversion.

Authors:  David Schwartzman; Shailesh Kumar Musley; Charles Swerdlow; Robert H Hoyt; Eduardo N Warman
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

8.  Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry.

Authors:  F G Cosio; J Palacios; J M Vidal; E G Cocina; M A Gómez-Sánchez; L Tamargo
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

9.  Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation.

Authors:  P J Stafford; J Cooper; D P de Bono; R Vincent; C J Garratt
Journal:  Br Heart J       Date:  1995-12

10.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

View more
  9 in total

1.  Usefulness of P-wave signal averaging to predict atrial fibrillation recurrences after electrical cardioversion.

Authors:  Coralie Blanche; Nam Tran; David Carballo; Fabio Rigamonti; Haran Burri; Marc Zimmermann
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-01-08       Impact factor: 1.468

2.  Electrocardiographic P-Wave Duration, QT Interval, T Peak to End Interval and Tp-e/QT Ratio in Pregnancy with Respect to Trimesters.

Authors:  Asli Tanindi; Nilufer Akgun; Emre Goksan Pabuccu; Aslı Yarci Gursoy; Ebru Yüce; Hasan Fehmi Tore; Candan Iltemir Duvan
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-06-18       Impact factor: 1.468

Review 3.  Atrial Fibrillation Predictors: Importance of the Electrocardiogram.

Authors:  David M German; Muammar M Kabir; Thomas A Dewland; Charles A Henrikson; Larisa G Tereshchenko
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-11-02       Impact factor: 1.468

Review 4.  P wave indices: current status and future directions in epidemiology, clinical, and research applications.

Authors:  Jared W Magnani; Mary Ann Williamson; Patrick T Ellinor; Kevin M Monahan; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02

5.  Prolonged P-wave duration is associated with atrial fibrillation recurrence after successful pulmonary vein isolation for paroxysmal atrial fibrillation.

Authors:  Jane Caldwell; Sahil Koppikar; Walid Barake; Damian Redfearn; Kevin Michael; Christopher Simpson; Wilma Hopman; Adrian Baranchuk
Journal:  J Interv Card Electrophysiol       Date:  2013-12-04       Impact factor: 1.900

6.  Developing a New Computer-Aided Clinical Decision Support System for Prediction of Successful Postcardioversion Patients with Persistent Atrial Fibrillation.

Authors:  Mark Sterling; David T Huang; Behnaz Ghoraani
Journal:  Comput Math Methods Med       Date:  2015-05-18       Impact factor: 2.238

Review 7.  Electrophysiological Mechanisms of Bayés Syndrome: Insights from Clinical and Mouse Studies.

Authors:  Gary Tse; Eric Tsz Him Lai; Jie Ming Yeo; Bryan P Yan
Journal:  Front Physiol       Date:  2016-05-31       Impact factor: 4.566

8.  Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation.

Authors:  Jia-Hui Li; Hai-Yang Xie; Yan-Qiao Chen; Zhong-Jing Cao; Qing-Hui Tang; Xiao-Gang Guo; Qi Sun; Jian Ma
Journal:  Front Physiol       Date:  2021-11-30       Impact factor: 4.566

9.  P-wave signal-averaged electrocardiography: Reference values, clinical correlates, and heritability in the Framingham Heart Study.

Authors:  Jelena Kornej; Jared W Magnani; Sarah R Preis; Elsayed Z Soliman; Ludovic Trinquart; Darae Ko; Emelia J Benjamin; Honghuang Lin
Journal:  Heart Rhythm       Date:  2021-05-11       Impact factor: 6.343

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.